IP Library Patent Application 18031899
Patent Application
App. No. 18/031,899

METHODS FOR TREATING CHOLESTATIC PRURITUS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/031,899
Abstract

Methods of treating pruritus, including cholestatic pruritus, particularly cholestatic pruritus in primary biliary cholangitis comprising administration of the compound or a pharmaceutically acceptable salt thereof, are disclosed.

Claims (11)

1 - 13 . (canceled)

14 . A method of treatment of cholestatic pruritus in primary biliary cholangitis in a human in need thereof comprising administering to said human the compound

or a pharmaceutically acceptable salt thereof, wherein the compound is administered in an amount of approximately 40 mg, twice daily.

15 . A method of treatment according to claim 14 , wherein such administration results in improvement in itch.

16 . The method of treatment according to claim 14 wherein the compound is administered orally.

17 . The method of treatment according to claim 14 wherein the compound is:

18 . The method of treatment according to claim 14 wherein said improvement in itch is demonstrated by a mean difference from placebo in mean change from baseline Monthly Itch Score of at least −0.5.

19 . The method of treatment according to claim 14 wherein said improvement in itch is demonstrated by a mean difference from placebo in mean change from baseline Monthly Itch Score of at least −0.9.

20 . The method of treatment according to claim 14 wherein the treatment period is at least 12 weeks in duration.

21 . A method of treatment of cholestatic pruritus in primary biliary cholangitis in a human in need thereof comprising administering to said human the compound

or a pharmaceutically acceptable salt thereof, wherein the compound is administered twice daily, and wherein such administration results in improvement in itch.

Assignments (2)
CHANGE OF ADDRESS Recorded Apr 16, 2025
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 070854/0469 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2023
From: KENDRICK, STUART FREDERICK WILLIAM; MCLAUGHLIN, MEGAN M
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 063322/0055 →